Evidence & regulatory context
- Mechanism
- Code name too ambiguous for a confident ChEMBL match; left unresolved rather than guessing.
- Target
- Not recorded
- Injury models
- Chemical/toxin
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
RatChemical/toxinSprague-DawleyMaleOralFrom 2 days before until 4 days after toxin injection
Model: Shiga toxin 2 injection (haemolytic uraemic syndrome model)
Oral C-9 decreased mortality to 50% and reduced renal and intestinal injury from Shiga toxin 2, with prophylactic benefit when given before challenge.
Extraction: extract · Supplied extraction confidence: 0.8. Machine-extracted fields require source verification.
